Gray Market

September 2017 : Generic Drugs - Vol.14 No. 9 - Page #8
Category: Generics Manufacturers

The trend of diminishing reliance on the gray market to procure pharmaceuticals saw a disturbing reversal this year, despite the fact that most facilities with a policy in place forbid this potentially dangerous practice. It appears to be time for the 57% of facilities without an official policy in place to commit to crafting one.


Like what you've read? Please log in or create a free account to enjoy more of what has to offer.

Current Issue